Cargando…
Pneumocystis jirevocii and SARS-CoV-2 Co-Infection: A Common Feature in Transplant Recipients?
COVID-19 might potentially give rise to a more severe infection in solid organ transplant recipients due to their chronic immunosuppression. These patients are at a higher risk of developing concurrent or secondary bacterial and fungal infections. Co-infections can increase systemic inflammation inf...
Autores principales: | De Francesco, Maria A., Alberici, Federico, Bossini, Nicola, Scolari, Francesco, Pascucci, Federico, Tomasoni, Gabriele, Caruso, Arnaldo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565862/ https://www.ncbi.nlm.nih.gov/pubmed/32962148 http://dx.doi.org/10.3390/vaccines8030544 |
Ejemplares similares
-
Hypercalcemia is common during Pneumocystis pneumonia in kidney transplant recipients
por: Hamroun, Aghilès, et al.
Publicado: (2019) -
Co-infection of chlamydia pneumoniae and mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features
por: De Francesco, Maria Antonia, et al.
Publicado: (2021) -
A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia
por: Alberici, Federico, et al.
Publicado: (2020) -
The Authors Reply
por: Alberici, Federico, et al.
Publicado: (2020) -
The place of cyclical therapy for the treatment of membranous nephropathy in the era of rituximab
por: Alberici, Federico, et al.
Publicado: (2023)